• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过流式细胞术研究甲氨蝶呤对培养的人白血病细胞的细胞毒性。

Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.

作者信息

Taylor I W, Tattersall M H

出版信息

Cancer Res. 1981 Apr;41(4):1549-58.

PMID:6163527
Abstract

Methotrexate (MTX)(2 x 10(-8) M) inhibited DNA synthesis in CCRF-CEM cells, causing cells to accumulate in early S phase while cellular RNA content and cell size continued to increase. Two-parameter flow cytometric analysis of DNA and RNA showed these cells to be unbalanced with excessive RNA relative to DNA content. Fifty % of cells remained viable after a 96-hr exposure to 2 x 10(-8) M MTX. In contrast, 10(-4) M MTX inhibited cell cycle progression of cells in both G1 and S phases and also prevented the development of unbalanced growth. In this instance, cell viability was reduced to 10% after 96 hr of drug exposure. The relative contribution of inhibition of thymidylate and purine biosynthesis to MTX cytotoxicity was investigated by addition of exogenous thymidine (10(-5) M) or hypoxanthine (10(-4) M). Thymidine reduced the cytotoxicity and inhibition of DNA synthesis caused by both doses of MTX and prevented classical unbalanced growth with 2 x 10(-8) m MTX; treatment with 10(-4) M MTX resulted in a form of unbalanced growth where cells had a relative excess of DNA compared with RNA content. The addition of hypoxanthine enhanced the classical unbalanced growth pattern seen with 2 x 10(-8) M MTX but was accompanied by a partial reduction of both the MTX-induced cytotoxicity and the inhibition of DNA synthesis (to an extent similar to that seen with exogenous thymidine). Potentiation of cell killing was observed with the addition of hypoxanthine to cells treated with 10(-4) M MTX. Complete rescue from MTX cytotoxicity at both concentrations was found only when both thymidine and hypoxanthine were present. These finding suggest that MTX cytotoxicity is associated with inhibition of DNA synthesis resulting from the disturbance of both thymidylate and purine biosynthesis.

摘要

甲氨蝶呤(MTX)(2×10⁻⁸ M)抑制CCRF - CEM细胞中的DNA合成,使细胞积聚在S期早期,而细胞RNA含量和细胞大小持续增加。对DNA和RNA进行双参数流式细胞术分析显示,这些细胞不平衡,RNA相对于DNA含量过多。暴露于2×10⁻⁸ M MTX 96小时后,50%的细胞仍存活。相比之下,10⁻⁴ M MTX抑制G1期和S期细胞的细胞周期进程,并阻止不平衡生长的发展。在这种情况下,药物暴露96小时后细胞活力降至10%。通过添加外源性胸苷(10⁻⁵ M)或次黄嘌呤(10⁻⁴ M)研究了胸苷酸和嘌呤生物合成抑制对MTX细胞毒性的相对贡献。胸苷降低了两种剂量MTX引起的细胞毒性和DNA合成抑制,并防止了2×10⁻⁸ m MTX引起的典型不平衡生长;用10⁻⁴ M MTX处理导致一种不平衡生长形式,即细胞的DNA相对于RNA含量相对过量。添加次黄嘌呤增强了2×10⁻⁸ M MTX所见的典型不平衡生长模式,但同时MTX诱导的细胞毒性和DNA合成抑制均部分降低(降低程度与外源性胸苷所见相似)。在10⁻⁴ M MTX处理的细胞中添加次黄嘌呤观察到细胞杀伤增强。仅当胸苷和次黄嘌呤都存在时,才发现两种浓度的MTX细胞毒性都能完全解除。这些发现表明,MTX细胞毒性与胸苷酸和嘌呤生物合成紊乱导致的DNA合成抑制有关。

相似文献

1
Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.通过流式细胞术研究甲氨蝶呤对培养的人白血病细胞的细胞毒性。
Cancer Res. 1981 Apr;41(4):1549-58.
2
Biochemical and cell cycle perturbations in methotrexate-treated cells.
Mol Pharmacol. 1982 Jan;21(1):204-10.
3
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.聚谷氨酸化对CCRF - CEM细胞系中雷替曲塞和甲氨蝶呤敏感性的影响与药物诱导的从头胸苷酸和嘌呤生物合成抑制的关系。
Clin Cancer Res. 1999 Sep;5(9):2548-58.
4
Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.胸苷酸和嘌呤合成的抗叶酸抑制剂对WiDr结肠癌细胞的细胞毒性。
Cancer Res. 1993 Dec 1;53(23):5697-706.
5
Inhibition of methotrexate-induced differentiation of cultured human choriocarcinoma (BeWo) cells by thymidine.
Cancer Res. 1987 Oct 1;47(19):5059-64.
6
Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.通过溴脱氧尿苷/DNA分析对甲氨蝶呤处理的小鼠L1210白血病细胞的细胞周期扰动进行流式细胞术分析。
Cancer Res. 1988 Aug 1;48(15):4288-93.
7
Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.胸苷酸合成酶作为甲氨蝶呤敏感和耐药的人头颈癌及白血病细胞系中生长抑制的靶点。
Oncol Res. 1997;9(3):139-47.
8
Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate.从骨肉瘤患者中分离肿瘤细胞并分析其对甲氨蝶呤的敏感性。
Cancer Res. 1981 Sep;41(9 Pt 1):3621-8.
9
Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.高剂量甲氨蝶呤治疗指数的提高:小鼠中胸腺嘧啶核苷-嘌呤解救与亚叶酸解救的比较
Cancer Res. 1984 Jun;44(6):2278-84.
10
[Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
Hokkaido Igaku Zasshi. 1983 Sep;58(5):467-82.

引用本文的文献

1
PAX3-FOXO1 Drives Targetable Cell State-Dependent Metabolic Vulnerabilities in Rhabdomyosarcoma.PAX3-FOXO1驱动横纹肌肉瘤中可靶向的细胞状态依赖性代谢脆弱性。
Cancer Res. 2025 Sep 5. doi: 10.1158/0008-5472.CAN-25-0315.
2
Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis.亚甲基四氢叶酸脱氢酶1的人类突变会损害细胞核内胸腺嘧啶核苷酸的从头生物合成。
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):400-5. doi: 10.1073/pnas.1414555112. Epub 2014 Dec 29.
3
Methotrexate released in vitro from bone cement inhibits human stem cell proliferation in S/G2 phase.
骨水泥中释放的甲氨蝶呤体外抑制人干细胞在 S/G2 期的增殖。
Int Orthop. 2010 Feb;34(1):137-42. doi: 10.1007/s00264-008-0717-6. Epub 2009 Feb 11.
4
A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus.一类新型的基于亲脂性喹唑啉的叶酸类似物:具有非叶酸依赖作用位点的细胞毒性剂。
Br J Cancer. 1999 Apr;79(11-12):1692-701. doi: 10.1038/sj.bjc.6690270.
5
Treatment of the rat R-1 rhabdomyosarcoma with methotrexate and radiation; effects of timing on cell survival and tumour growth delay.用甲氨蝶呤和放疗治疗大鼠R-1横纹肌肉瘤;时间安排对细胞存活和肿瘤生长延迟的影响。
J Cancer Res Clin Oncol. 1993;119(4):215-20. doi: 10.1007/BF01624433.
6
The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.通过流式细胞术和染色体数分析研究长春花生物碱增强甲氨蝶呤耐药(L1210/R7A)细胞系敏感性的作用。
Cancer Chemother Pharmacol. 1984;13(1):47-53. doi: 10.1007/BF00401447.
7
Biological and biochemical properties of new anticancer folate antagonists.新型抗癌叶酸拮抗剂的生物学和生物化学特性
Cancer Metastasis Rev. 1987;5(3):251-70. doi: 10.1007/BF00047000.
8
Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture.
Cancer Chemother Pharmacol. 1988;22(1):26-32. doi: 10.1007/BF00254176.
9
Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay.在淋巴细胞克隆试验中,死亡细胞代谢产物对抗叶酸细胞毒性的调节作用。
Br J Cancer. 1988 May;57(5):459-63. doi: 10.1038/bjc.1988.107.
10
Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.核苷转运抑制剂对甲氨蝶呤体外淋巴细胞毒性的增强作用。
Br J Cancer. 1989 Mar;59(3):381-4. doi: 10.1038/bjc.1989.76.